Safety and efficacy of dabigatran versus warfarin in Asian patients with atrial fibrillation

Safety and efficacy of dabigatran versus warfarin in Asian patients with atrial fibrillation

Introduction: Nonvalvular atrial fibrillation is a common cause of cardioembolic stroke which accounts around 50% of all cardioembolic emboli. Oral anticoagulants remain the main choice of stroke prevention in patients with atrial fibrillation. Our study is aimed to determine the safety (absence o...

Full description

Bibliographic Details
Main Authors:	Inche Mat, Liyana Najwa, Ooi, Qi Wen, Johari, Nurul Natasha Ashikin, Subramaniam, Rooban Raao, Wan Sulaiman, Wan Aliaa, Hoo, Fan Kee, Chia, Peck Kee, Basri, Hamidon
Format:	Article
Language:	English
Published:	Faculty of Medicine and Health Science, Universiti Putra Malaysia 2020
Online Access:	http://psasir.upm.edu.my/id/eprint/87519/1/2020120208341112_MJMHS_0712.pdf

Similar Items

Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation
by: Yi‐Hsin Chan, et al.
Published: (2018-04-01)

A comparison of dabigatran and warfarin for stroke prevention in elderly Asian population with nonvalvular atrial fibrillation: an audit of current practice in Malaysia
by: Yap, Swee Hien, et al.
Published: (2017)

A rare case of vein of galen thrombosis: exploring a potential role for novel oral anticoagulants (NOACs) in cerebral deep vein thrombosis
by: Inche Mat, Liyana Najwa, et al.
Published: (2017)

Incomplete anterior choroidal artery syndrome in a pregnant female
by: Inche Mat, Liyana Najwa, et al.
Published: (2019)

Incomplete anterior choroidal artery syndrome in a pregnant female
by: Liyana Najwa Inche Mat, et al.
Published: (2019-01-01)

CAN CLOPIDOGREL FULLY SUBSTITUTE WARFARIN AND DABIGATRAN IN ATRIAL FIBRILLATION?
by: A. B. Sumarokov
Published: (2013-08-01)

Survey of the use of warfarin and the newer anticoagulant dabigatran in patients with atrial fibrillation
by: Choi JC, et al.
Published: (2014-02-01)

Uninterrupted dabigatran is safer than warfarin in patients undergoing ablation for atrial fibrillation
by: Michael Spartalis, MD, MSc, PhD, et al.
Published: (2017-12-01)

EFFECT OF ANTICOAGULANT TREATMENT OF DABIGATRAN AND WARFARIN ON HEMOSTASIS IN PATIENTS WITH LIVER CIRRHOSIS AND ATRIAL FIBRILATION.
by: A.E. Baylo, et al.
Published: (2022-02-01)

The Comparison of Therapeutic Efficacy Between Dabigatran Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation
by: Hongxia Li, et al.
Published: (2021-09-01)

Creutzfeldt-Jakob Disease (CJD) in Southeast Asia: a diagnostic challenge
by: Abdul Rashid, Anna Misya'il, et al.
Published: (2017)

Spontaneous bilateral basal ganglia haemorrhage secondary to methanol poisoning
by: Sohor, Norainon J, et al.
Published: (2024)

Acute disseminated encephalomyelitis in dengue viral infection
by: Wan Sulaiman, Wan Aliaa, et al.
Published: (2017)

Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation
by: Brandon K. Martinez, et al.
Published: (2018-04-01)

A single institution’s experience with using dabigatran, rivaroxaban and warfarin for prevention of thromboembolism in atrial fibrillation
by: Li Xin Chan, et al.
Published: (2018-03-01)

Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation
by: Faye L. Norby, et al.
Published: (2017-09-01)

Dabigatran Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation: An Evidence Based Case Report
by: Alvin Nursalim, et al.
Published: (2013-06-01)

Cost‐effectiveness analysis of dabigatran, rivaroxaban and warfarin in the prevention of stroke in patients with atrial fibrillation in China
by: Hongtao Wei, et al.
Published: (2021-01-01)

Comparison of benefit between dabigatran and warfarin among patients with atrial fibrillation: A systematic review
by: Amal K Sulieman
Published: (2016-01-01)

Predictive factors associated with severity of carpal tunnel syndrome in multiethnic Asian patients
by: Wan Sulaiman, Wan Aliaa, et al.
Published: (2017)

Healthcare utilization and costs for patients initiating Dabigatran or Warfarin
by: Shannon L. Reynolds, et al.
Published: (2017-06-01)

PHARMACOECONOMIC EVALUATION OF DABIGATRAN VS WARFARIN IN CARDIOVASCULAR EVENTS PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
by: Yu. B. Belousov, et al.
Published: (2015-12-01)

PHARMACOECONOMIC EVALUATION OF DABIGATRAN VS WARFARIN IN CARDIOVASCULAR EVENTS PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
by: Yu. B. Belousov, et al.
Published: (2015-12-01)

Acute brachial plexopathy: an unusual complication from Bee Sting
by: Hoo, Fan Kee, et al.
Published: (2014)

Cost-effectiveness of dabigatran versus genotype-guided management of warfarin therapy for stroke prevention in patients with atrial fibrillation.
by: Joyce H S You, et al.
Published: (2012-01-01)

Comparative effectiveness of warfarin, dabigatran, rivaroxaban and apixaban in non-valvular atrial fibrillation: A nationwide pharmacoepidemiological study.
by: Lars J Kjerpeseth, et al.
Published: (2019-01-01)

Repetitive Transcranial Magnetic Stimulation of the Primary Motor Cortex beyond Motor Rehabilitation: A Review of the Current Evidence
by: Abdulhameed Tomeh, et al.
Published: (2022-06-01)

Repetitive transcranial magnetic stimulation of the primary motor cortex beyond motor rehabilitation: a review of the current evidence
by: Tomeh, Abdulhameed, et al.
Published: (2022)

Acute Myocardial Infarction after Switching from Warfarin to Dabigatran
by: Wael Abuzeid, et al.
Published: (2015-01-01)

Regional Emergency Stroke Quick-Response (RESQ) Network: a proposed paradigm of Malaysia stroke care services
by: Chia, Peck Kee, et al.
Published: (2020)

Discontinuation risk comparison among 'real-world' newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban.
by: Gregory Y H Lip, et al.
Published: (2018-01-01)

Treatment Persistence and Discontinuation with Rivaroxaban, Dabigatran, and Warfarin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation in the United States.
by: Craig I Coleman, et al.
Published: (2016-01-01)

Slimmer’s palsy following an intermittent fasting diet
by: Janudin Baharin, et al.
Published: (2022-12-01)

Length of hospitalization and mortality for bleeding during treatment with warfarin, dabigatran, or rivaroxaban.
by: Blake Charlton, et al.
Published: (2018-01-01)

Effectiveness and safety of dabigatran versus warfarin in “real-world” Japanese patients with atrial fibrillation: A single-center observational study
by: Miyoko Naganuma, PhD, et al.
Published: (2017-04-01)

Factors affecting serum concentration of dabigatran in Asian patients with non-valvular atrial fibrillation
by: Shin-Yi Lin, et al.
Published: (2019-07-01)

Toxoplasma gondii: manipulation of host cell machinery in the journey from intestine to brain
by: Sulaiman, Wan Aliaa Wan, et al.
Published: (2017)

Anti-Wolbachia therapy for onchocerciasis & lymphatic filariasis: current perspectives
by: Wan Sulaiman, Wan Aliaa, et al.
Published: (2019)

Resolution of a warfarin and dabigatran-resistant left atrial appendage thrombus with apixaban
by: Yosuke Miwa, et al.
Published: (2016-06-01)

Stroke and novel coronavirus infection in humans: a systematic review and meta-analysis
by: Lee, Kai Wei, et al.
Published: (2020)